LAVENTAIR ELLIPTA 55 micrograms/22 micrograms, powder for inhalation in a single-dose container 30 doses, CIP 3400930082799
Active ingredients: Umeclidinium bromide, Vilanterol trifenatate, Umeclidinium, Vilanterol
Commercialized according to BDPMDispensing in France: Prescription only
Powder and powder for inhalation30 doses, CIP 3400930082799inhalée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- LAVENTAIR ELLIPTA 55 microgrammes/22 microgrammes, poudre pour inhalation en récipient unidose
- Pharmaceutical form
- poudre et poudre pour inhalation
- Route of administration
- inhalée
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 30 dose(s) avec inhalateur(s)
- Marketing authorisation holder
- GLAXOSMITHKLINE TRADING SERVICES (IRLANDE)
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 12 Nov 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
63989385CIP73008279CIP133400930082799Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| UMÉCLIDINIUMpoudre de bromure d’uméclidinium | 55 microgrammes · une dose délivrée | FT |
| BROMURE D'UMÉCLIDINIUMpoudre de bromure d’uméclidinium | 65 microgrammes · une dose délivrée | SA |
| VILANTÉROLpoudre de trifénatate de vilantérol | 22 microgrammes · une dose délivrée | FT |
| TRIFÉNATATE DE VILANTÉROLpoudre de trifénatate de vilantérol | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.